Sumitomo Mitsui Trust Group Inc. Grows Position in Molina Healthcare, Inc $MOH

Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Molina Healthcare, Inc (NYSE:MOH) by 4.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 156,969 shares of the company’s stock after purchasing an additional 6,684 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.29% of Molina Healthcare worth $46,761,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its holdings in Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after purchasing an additional 1,216,903 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Molina Healthcare by 8.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock worth $490,099,000 after buying an additional 117,796 shares in the last quarter. AQR Capital Management LLC lifted its holdings in shares of Molina Healthcare by 42.7% in the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock worth $288,125,000 after buying an additional 264,664 shares in the last quarter. Durable Capital Partners LP lifted its holdings in shares of Molina Healthcare by 13.1% in the first quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock worth $178,399,000 after buying an additional 62,899 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Molina Healthcare by 1.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 465,672 shares of the company’s stock worth $153,388,000 after buying an additional 7,021 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

MOH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. lowered their price target on shares of Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a report on Tuesday, July 29th. Morgan Stanley set a $158.00 price target on shares of Molina Healthcare in a report on Friday. Wells Fargo & Company increased their price target on shares of Molina Healthcare from $198.00 to $231.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Mizuho decreased their price objective on shares of Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating on the stock in a research report on Friday, July 11th. Finally, Robert W. Baird decreased their price objective on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $203.64.

Insider Buying and Selling

In other news, Director Ronna Romney sold 700 shares of the stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the sale, the director owned 17,131 shares of the company’s stock, valued at approximately $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO James Woys acquired 10,000 shares of the company’s stock in a transaction dated Monday, August 4th. The shares were bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the purchase, the chief operating officer owned 74,331 shares of the company’s stock, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their position. The disclosure for this purchase can be found here. 1.26% of the stock is owned by company insiders.

Molina Healthcare Stock Down 0.9%

Shares of NYSE MOH opened at $161.88 on Tuesday. Molina Healthcare, Inc has a one year low of $151.95 and a one year high of $359.97. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.68 and a quick ratio of 1.68. The firm’s 50 day simple moving average is $184.05 and its two-hundred day simple moving average is $236.74. The stock has a market capitalization of $8.77 billion, a P/E ratio of 10.02 and a beta of 0.55.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The business had revenue of $11.48 billion for the quarter, compared to the consensus estimate of $10.99 billion. During the same quarter in the previous year, the business earned $6.01 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. As a group, analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.